MGH

Recall · Commentary

What the historic Medihoney recall tells us about medical-grade honey QA

Recalls of honey-based wound dressings are rare, but they tell you exactly which parts of the manufacturing chain are load-bearing. A 2014-era voluntary recall of a Medihoney product line is a useful teaching case.

MedicalGradeHoney.com · 29 May 2026

The medical-grade honey category has a comparatively quiet recall record. That isn't an accident — gamma-sterilised honey in primary packaging is a chemically simple, microbiologically stable product. When a recall does happen, the cause is almost always one of three things: bioburden out of specification at release, primary packaging integrity, or a labelling/COA mismatch on the active (MGO) value.

The case in brief

Historic voluntary withdrawals of Medihoney-branded dressings — most notably the limited Class II actions in the mid-2010s — were triggered by packaging-seal integrity findings on specific lots rather than by the honey itself. No clinical safety signal, no MGO failure, no sterility-test failure on intact units. The QA file did exactly what a QA file is meant to do: catch a deviation at lot release and pull affected stock before it reached patients.

Recalls in this category test the manufacturing system, not the honey. When the system is well-designed, the honey is almost never the issue.
The teaching point

What a robust QA file actually covers

  • Pre-sterilisation bioburden — measured per lot under ISO 11737-1, with a dose-set established under ISO 11137 (typically VDmax25) to underwrite the 10⁻⁶ SAL target.
  • Primary-package seal integrity — dye penetration or vacuum-decay testing on a statistically representative sample of every lot, plus accelerated-age testing for shelf-life claims.
  • MGO release assay — HPLC quantification on every lot, with a documented retention spec post-sterilisation (industry norm: ≥ 95% of the labelled value).
  • Botanical attestation — leptosperin, DNA or pollen, confirming Leptospermum origin batch-by-batch.
  • Stability data — real-time at 25 °C/60% RH and accelerated at 40 °C/75% RH, with MGO, HMF and water-activity drift tracked to the labelled expiry.

How buyers should read a recall

A recall is a positive signal about a manufacturer's pharmacovigilance — it means the QA system is operating, not that it has failed. The diligence questions for a buyer post-recall are narrower than people assume: what was the root cause, what's the CAPA, has the same failure mode been ruled out across other lots? Honey chemistry is almost never the answer.

What to ask your supplier

Whether or not your supplier has ever issued a recall, ask for the same five documents: ISO 13485 certificate, sterilisation validation report, a current lot's COA with MGO and bioburden, a stability summary, and the supplier's complaint/recall history with CAPA references. A manufacturer who can produce all five in a week has the system you want. A manufacturer who can't is the risk.

See also our reference articles on how medical grade honey is sterilised and why MGO survives gamma irradiation.

Cite this article

MedicalGradeHoney.com (2026). What the historic Medihoney recall tells us about medical-grade honey QA. medicalgradehoney.com/news/medihoney-recall-context